Excessive fatty acids activate PRMT5 / MDM2 /Drosha pathway to regulate miRNA biogenesis and lipid metabolism
Liver International · 2024
DOI: 10.1111/liv.15906 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver International, 2024. Verfasst von Aijun Hou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Drug Safety Evaluation and Research, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Scien…. Hauptthemen laut MEDLINE: Lipid Metabolism, MicroRNAs, Non-alcoholic Fatty Liver Disease, Protein-Arginine N-Methyltransferases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Excessive fatty acids in the liver lead to the accumulation of lipotoxic lipids and then cellular stress to further evoke the related disease, like non‐alcoholic fatty liver disease (NAFLD). As reported, fatty acid stimulation can cause some specific miRNA dysregulation, which caused us to investigate the relationship between miRNA biogenesis and fatty acid overload.
Methods
Gene expression omnibus (GEO) dataset analysis, miRNA‐seq, miRNA cleavage assay, RT‐qPCR, western blotting, immunofluorescence and co‐immunoprecipitation (co‐IP) were used to reveal the change of miRNAs under pathological status and explore the relevant mechanism. High fat, high fructose, high cholesterol (HFHFrHC) diet‐fed mice transfected with AAV2/8‐shDrosha or AAV2/8‐shPRMT5 were established to investigate the in vivo effects of Drosha or PRMT5 on NAFLD phenotype.
Results
We discovered that the cleavage of miRNAs was inhibited by analysing miRNA contents and detecting some representative pri‐miRNAs in multiple mouse and cell models, which was further verified by the reduction of the Microprocessor activity in the presence of palmitic acid (PA). In vitro, PA could induce Drosha, the core RNase III in the Microprocessor complex, degrading through the proteasome‐mediated pathway, while in vivo, knockdown of Drosha significantly promoted NAFLD to develop to a more serious stage. Mechanistically, our results demonstrated that PA can increase the methyltransferase activity of PRMT5 to degrade Drosha through MDM2, a ubiquitin E3 ligase for Drosha. The above results indicated that PRMT5 may be a critical regulator in lipid metabolism during NAFLD, which was confirmed by the knocking down of PRMT5 improved aberrant lipid metabolism in vitro and in vivo.
Conclusions
We first demonstrated the relationship between miRNA dosage and NAFLD and proved that PA can activate the PRMT5‐MDM2‐Drosha signalling pathway to regulate miRNA biogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Drug Safety Evaluation and Research, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
- School of Pharmacy, University of Chinese Academy of Sciences, Beijing, China.
- School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, China.
- Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, China.
ORCID-Profile: Jing Chen
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Hou, A., Xu, X., Zhang, Y., He, H., Feng, Y., Fan, W., Tan, R., Gong, L., & Chen, J. (2024). Excessive fatty acids activate PRMT5 / MDM2 /Drosha pathway to regulate miRNA biogenesis and lipid metabolism. Liver International. https://doi.org/10.1111/liv.15906
Vancouver
Hou A, Xu X, Zhang Y, He H, Feng Y, Fan W, et al. Excessive fatty acids activate PRMT5 / MDM2 /Drosha pathway to regulate miRNA biogenesis and lipid metabolism. Liver International. 2024. doi:10.1111/liv.15906
BibTeX
@article{Hou2024,
author = {Hou, Aijun and Xu, Xiaoding and Zhang, Yu and He, Hongxiu and Feng, Yihan and Fan, Wenhui and Tan, Rongrong and Gong, Likun and Chen, Jing},
title = {Excessive fatty acids activate PRMT5 / MDM2 /Drosha pathway to regulate miRNA biogenesis and lipid metabolism},
journal = {Liver International},
year = {2024},
doi = {10.1111/liv.15906}
}
EUVIMED